AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2021
Sep 8, 2021
30786_dirs_2021-09-08_9bffc370-7fae-4298-aaad-4406a255abb2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2021-09-03
Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-03 | Bio-Rad A Common Stock | M | 2319 | $.00 | Acquired | 422200 | Direct |
| 2021-09-03 | Bio-Rad A Common Stock | F | 1150 | $819.70 | Disposed | 421050 | Direct |
| 2021-09-04 | Bio-Rad A Common Stock | M | 2600 | $.00 | Acquired | 423650 | Direct |
| 2021-09-04 | Bio-Rad A Common Stock | F | 1290 | $819.70 | Disposed | 422360 | Direct |
| 2021-09-05 | Bio-Rad A Common Stock | M | 2600 | $.00 | Acquired | 424960 | Direct |
| 2021-09-05 | Bio-Rad A Common Stock | F | 1290 | $819.70 | Disposed | 423670 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-03 | Restricted Stock Units | $0 | M | 2319 | Disposed | Bio-Rad A Common Stock (2319) | Direct | |
| 2021-09-04 | Restricted Stock Units | $0 | M | 2600 | Disposed | Bio-Rad A Common Stock (2600) | Direct | |
| 2021-09-05 | Restricted Stock Units | $0 | M | 2600 | Disposed | Bio-Rad A Common Stock (2600) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad B Common Stock | 12838 | Indirect |
| Bio-Rad B Common Stock | 4060054 | Indirect |
| Bio-Rad B Common Stock | 298274 | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: The reporting person disclaims beneficial ownership of these shares.
F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F5: On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F6: On September 4, 2018, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F7: On September 5, 2017, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.